A generic version of Xarelto (rivaroxaban) is now available in the United States, but only for one specific dose. In March 2025, the FDA approved the first generics of Xarelto in the 2.5 mg tablet strength. The higher doses most commonly prescribed for blood clots and stroke prevention, including the 10 mg, 15 mg, and 20 mg tablets, do not yet have generic versions on the market.
What the Generic Covers
The approved generic rivaroxaban 2.5 mg tablets are indicated for two specific conditions: reducing the risk of major cardiovascular events in adults with coronary artery disease, and reducing the risk of blood clot-related events in adults with peripheral artery disease. This is a relatively narrow slice of the Xarelto market. Most people taking Xarelto are prescribed higher doses for conditions like atrial fibrillation, deep vein thrombosis, or pulmonary embolism, and those patients don’t have a generic option yet.
When Higher-Dose Generics May Arrive
Xarelto’s solid oral formulation patent, including its pediatric exclusivity extension, is scheduled to expire in May 2025. That expiration opens the door for generic manufacturers to bring higher-dose versions to market. Once patent protection lapses, it typically takes several months for generic products to clear manufacturing and distribution hurdles, though some companies may already have FDA approval in hand and be waiting for the patent window to open.
Some patent records list additional protections extending as far as 2034, which could complicate the timeline depending on how patent disputes play out. The practical reality is that the 2.5 mg generic is here now, and broader generic availability for the more commonly prescribed doses is expected to follow, though exact dates remain uncertain.
How Much the Generic Saves
For the 2.5 mg dose, the price difference is meaningful but not dramatic. A 30-day supply of generic rivaroxaban 2.5 mg runs about $276 at average retail pricing, compared to roughly $355 for brand-name Xarelto at the same dose. That’s about a 22% savings.
The higher doses of brand-name Xarelto remain expensive. A 30-day supply of the 10 mg or 20 mg tablets costs around $745 at retail, and the 15 mg tablets run about $700. For context, warfarin, the older blood thinner that works through a different mechanism, costs roughly $8 for a 30-day supply. Eliquis, the other widely prescribed newer blood thinner that works similarly to Xarelto, costs about $351 for a 30-day supply and does not have a generic available yet either.
Are Generics Equally Effective?
Generic rivaroxaban must meet the same FDA standards as every other generic drug. To earn approval, manufacturers must demonstrate that their product delivers the active ingredient into the bloodstream at the same rate and to the same extent as the brand-name version. The FDA requires that generics contain the identical active ingredient, in the identical dose, in the identical dosage form. The expected result is the same clinical effect and safety profile as brand-name Xarelto.
The inactive ingredients (fillers, binders, coatings) can differ between generics and brand-name products. In rare cases, people with sensitivities to specific inactive ingredients may notice a difference, but the therapeutic effect should be equivalent.
How to Lower Costs in the Meantime
If you’re taking one of the higher doses without a generic option, the manufacturer offers a savings card called XARELTO withMe. Eligible patients with commercial or private insurance can pay as little as $10 per fill. The card has a per-fill limit and an annual maximum benefit that Johnson & Johnson can change without notice.
The savings card is not available to anyone on Medicare, Medicaid, TRICARE, Veterans Administration benefits, or other government-funded insurance. Patients enrolled in health plans that partner with SaveOnSP, or plans that adjust copay obligations based on manufacturer assistance programs, are also excluded or may receive reduced benefits.
Pharmacy discount programs like GoodRx can also reduce the retail price, though the savings vary by pharmacy and location. If cost is a significant barrier and you’re taking Xarelto for a condition where warfarin is an appropriate alternative, that switch could save hundreds of dollars per month, though warfarin requires regular blood monitoring and dietary considerations that newer blood thinners don’t.